A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT07695597
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 240 participants
- Registry
-
NCT07695597
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07695597. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-15 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
- Condition
- Mixed Hyperlipidemia
- Intervention (Drug)
- SYH2070
- Intervention (Drug)
- Placebo
- Lead sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Record details
- Record id
cardio:ct-nct07695597- Content hash
b70ed9bd9a087747afb9112a933e67b4a965c45ec0172b28aec05a46b452fd07